Researchers are raising alarms about potentially lethal fungi that may proliferate in parts of the US, Europe, and Asia. A study, recently published in a preprint format on Research Square—which hasn’t yet been peer-reviewed—suggests that a rise in global temperatures could significantly escalate infections caused by Aspergillus, a type of fungus that flourishes in warm, humid conditions. This infection, termed aspergillosis, poses threats not only to humans but also to livestock and plants.
The research employed scientific modeling to forecast areas where Aspergillus might expand, based on differing climate scenarios. Predicted results indicate that by 2100, the frequency of these fungi could jump by as much as 77%, potentially exposing millions in Europe to the infection.
Jacob Glanville, the CEO of a biotechnology company in San Francisco, was not part of the research but looked over the findings. He noted that the study reflects how climate change scenarios can alter the habitats for certain pulmonary and systemic fungal infections.
Jatin M. Vyas, a professor of medicine and infectious diseases at Columbia University, concurred, expressing concerns that Aspergillus could become more common as climates warm. He mentioned that there’s a troubling rise in cases, particularly in milder regions worldwide.
Cornelia Scranty from the VA Pittsburgh Health System has observed an uptick in human fungal infections, alongside threats to agriculture and veterinary medicine. She emphasized that given Aspergillus is prevalent in the environment and climate change promotes its growth, exposure levels might rise for both humans and agriculture.
Potential Risks of Infection
Typically, for healthy individuals, Aspergillus spores don’t trigger serious issues. As one expert noted, most people breathe in a few spores daily. When the immune system works well, these spores are typically eliminated, preventing illness.
However, those with compromised immune systems can face severe consequences. For example, individuals undergoing chemotherapy could risk serious lung infections, Clancy warned. He pointed out that these infections could even lead to pneumonia or affect other body organs.
Allergy-like symptoms and worsened asthma can also manifest in individuals predisposed to these conditions, even if they aren’t immunosuppressed. Vyas highlighted this risk, indicating that individuals who are ill and must be hospitalized could experience grave issues if infected by Aspergillus.
Granville emphasized that elderly individuals and those with asthma are particularly vulnerable. He mentioned a global trend towards an aging population that also sees a rise in asthma cases, which is concerning.
In light of the challenges posed by diagnosing and treating Aspergillus infections, Vyas pointed out the difficulties. He noted a lack of effective medication for invasive fungal infections, which escalates the severity of the situation.
Prevention and Protection
Given that Aspergillus is rooted in soil, it’s hard to completely avoid exposure, according to Vyas. He advised those with compromised immune systems to discuss soil interaction with their doctors. Vyas concluded that understanding how Aspergillus causes illness, improving diagnostic methods, and developing better treatments are critical areas of focus.
Glanville added that early-stage diagnoses often miss these infections and mentioned that there are antifungal treatments available. He called for heightened medical training to identify these infections and to encourage the development of new antifungal options.
In summary, those aware of being immunosuppressed or taking medications that could weaken their immune systems should consult their healthcare providers about protective actions. The risks posed by Aspergillus and the challenges in managing serious infections make this a pressing health concern.
